Recipharm in discussions with Alcon regarding manufacturing agreement

Published: 7-Sep-2015
Manufacturing Finance

Agreement in principle to enter into a long-term manufacturing agreement for a range of ophthalmology products


Recipharm is currently in discussions with Alcon and has reached agreement in principle to enter into a long-term manufacturing agreement for a range of ophthalmology products.

As part of this arrangement, Recipharm will also acquire Alcon’s manufacturing facility located in Kaysersberg, France. The 260 people currently employed at the Kaysersberg site would transfer and continue to be offered employment by Recipharm following the date of the sale.

Further details will be made available following the end of consultation with the Works Council of Alcon and finalisation of the negotiations.

  • Companies:
  • Recipharm
  • Alcon Group
See more

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

Read more
The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  3. TekniPlex Healthcare to showcase expanded capacity and sustainability solutions at Pharmapack Company highlights EU-based advancements in injection blow molding, multilayer blown films, and sustainable blister packaging
  4. ACG expands global footprint with new capsule manufacturing facility in Thailand New capsule manufacturing facility in Rayong, Thailand, is strategically positioned to serve key Asian markets

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Manufacturing

Recipharm expands oral solid development and pilot scaling capabilities at Zwickau site

The CDMO's facility now has a range of pilot-scale OSD manufacturing capabilities, such as blending, hard capsule filling and tableting
Manufacturing

ReciBioPharm partners with Hongene Biotech to provide sgRNA manufacturing capabilities

ReciBioPharm will now offer sgRNA manufacturing capabilities on top of its current mRNA, LNP and fill-finish services
Training & Education

Women in pharma: the battle against mansplaining continues

Prejudice in the workplace is an affliction suffered by many, but how can the industry be free from this nasty virus?
Manufacturing

Recipharm, Medspray and Resyca enter into license agreement to develop nasally-delivered soft mist drug products

Recipharm, Medspray and Resyca have entered an exclusive collaboration and licensing agreement to develop soft mist nasal delivery devices for single and combination drug products.
Manufacturing

Overcoming bio/pharmaceutical production hurdles: an industry insider perspective

From F-gas regulation to finance and from biologics to personalised medicines, the global drug production environment faces a number of challenges that could potentially stifle innovation and profitability. Dr Kevin Robinson (KSR) recently spoke to key players in the supplier and outsourcing community to better understand what services and solutions are available to keep the pipeline flowing
Manufacturing

Recipharm’s analytical lab brings testing capabilities to global markets

Fully cGMP/cGLP compliant, the 5,000 sqft lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers
Manufacturing

BES completes $4.8m refurb for Recipharm

The 4000 sqm facility, located in King’s Lynn, has seen an extensive redesign and refurbishment
Subscribe now